Distinguishing primary hepatocellular carcinoma (HCC) from metastatic carcinomas to the liver is often difficult, if not impossible, particularly in needle biopsy and fine-needle aspiration specimens. In an attempt to identify a specific immunohistochemical profile that would distinguish HCC from me
Recent immunohistochemical markers in the differential diagnosis of primary and metastatic carcinomas of the liver
β Scribed by Murat Gokden; Anjali Shinde
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 226 KB
- Volume
- 33
- Category
- Article
- ISSN
- 8755-1039
- DOI
- 10.1002/dc.20345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The aim of this study was to analyse the diagnostic value of selected glyco- and immunohistochemical probes for discrimination between mesotheliomas and metastatic carcinomas within the pleura, and to evaluate prognostic indicators in the tested panel. A panel of nine markers (five antibodies, two n
NOBORU TERAYAMA, TADASHI TERADA, AND YASUNI NAKANUMA giogenesis and angioarchitecture in metastatic liver cancer Background/Aims. To clarify the angiogenetic process and their blood supply. Most metastatic tumors in the liver and the origin of tumor vessels in human metastatic are supplied by hepati
A series of 33 tumor cases (13 fine-needle aspirates and 20 effusion specimens) were evaluated for the expression of two cytokeratin (CK) subtypes; CK 20, expressed primarily in tumors of the GI tract, mucinous ovarian tumors and transitional cell carcinomas, and CK 7, found chiefly in non-GI tract
## Background: Difficulties with cytologic diagnoses on fine-needle aspiration cytology (fnac) of the liver can be overcome by the application of immunocytochemical panels applied on smears. the aim of the current study was to analyze the performance of a panel of monoclonal antibodies to different
The aim of the present study was to examine the correlation between the immunohistochemical findings and the serum markers for neuroendocrine (NE) cells in patients with carcinoma of the prostate. Preoperative serum values of chromogranin A (CgA), chromogranin B (CgB), pancreastatin (Pst), neuron-sp